Patent & IP news for August 20, 2010

Valuing Patents and Litigation from ipfinance.blogspot.com

Patent valuation has always been an art rather than a science. The value is often more dependent on the eye of the beholder than an "objective" value. And probably rightly so. A company that can ...

Share via E–mail | Twitter | Facebook

Two bites at the cherry, but no enhanced costs from patlit.blogspot.com

The recent decision of a hearing officer for the UK's Intellectual Property Office (IPO) in Wragg v Donnelly BL O/280/10, 9 August 2010 has already been picked up by the SOLO IP ...

Share via E–mail | Twitter | Facebook

The Technology Transfer Office: Starr-Up Help or Hindrance? from ipfinance.blogspot.com

The question of how university research is commercialized stands front and centre in most discussions about the impact of policy on innovation. Ever since the tectonic shift brought about by the Bayh-Dole Act in 1980 ...

Share via E–mail | Twitter | Facebook

Concluded Ex Parte Reexamination Results Ignored by District Court? from www.patentspostgrant.com

Estoppel of 35 USC § 317(b) Applies Only to Inter Partes Patent Reexamination

One of the risks often associated with ex parte patent reexamination is that an outcome favorable to a patent holder is considered ...

Share via E–mail | Twitter | Facebook

Article One Featured Researcher: Ramesh L. Shahabadkar (Ramesh) from info.articleonepartners.com

Article One Researcher Ramesh is the winner of two AOP Studies:

Min 120 – Minerva Industries Study regarding cell phones

JSA 857 – JSA Technologies Study

 

Through his work with Article One Ramesh has received $20,000 ...

Share via E–mail | Twitter | Facebook

Iconic sailor/nurse kiss of "Unconditional Surrender" returns to Hamilton, NJ from ipbiz.blogspot.com








The iconic World War II sailor made a brief trip from Hamilton, NJ to Times Square, but has now returned to Hamilton.
The sculpture is derived from the famous photograph.

Seward Johnson’s “Unconditional Surrender ...

Share via E–mail | Twitter | Facebook

Deep Rig from www.patenthawk.com

Transocean Offshore Deepwater Drilling innovates so humans can drive around on the cheap until they pollute themselves out of existence. And, as anything that lives in the Gulf of Mexico would tell you (if it ...

Share via E–mail | Twitter | Facebook

Friday fantasies from ipkitten.blogspot.com

"An apple a day keeps the doctor away,
A stitch in time saves nine.
So check the proverbial side bar list
For events -- and you'll be fine!".

Don't forget to check out the ...

Share via E–mail | Twitter | Facebook

IP Finance: a conference and a competition from ipfinance.blogspot.com

Intellectual Property and Finance 2010: exploring and explaining the financial dimensions of IPRs is the title of a one-day conference, organised by CLT Conferences and scheduled to be held in Central London on 20 October ...

Share via E–mail | Twitter | Facebook

Germany's rise to industrial power: due to lack of copyright? from ipkitten.blogspot.com

The economic historian Eckhard Höffner proposes a controversial theory: Germany's rise (and Great Britain's relative decline) in industrial and technological innovation in the early 19th century was due to a lack of copyright ...

Share via E–mail | Twitter | Facebook

IP Bewertung - RIP from ipfinance.blogspot.com

It's disappointing to hear of the apparent demise of the German Patent exploitation company IP Bewertung run by Guido von Scheffer from Hamburg. The company filed for bankruptcy in July and had made a ...

Share via E–mail | Twitter | Facebook

Chief Judge Rader's Views on Patentable Subject Matter - Part II from www.patentdocs.org

By Tim Peterson -- The Federal Circuit will soon be addressing the issue of patentable subject matter as it relates to biotechnology patents in a trilogy of cases: Prometheus Laboratories, Inc. v. Mayo Collaborative Services, Classen ...

Share via E–mail | Twitter | Facebook

Biotech/Pharma Docket from www.patentdocs.org

By James DeGiulio -- Lilly's Patent for Strattera Found Invalid, Lilly Appeals to Federal Circuit Teva Pharmaceuticals USA, Mylan Pharmaceuticals, and Apotex successfully argued that Eli Lilly's patent for the ADHD drug Strattera (U ...

Share via E–mail | Twitter | Facebook

PTO Files Amicus Brief in Therasense Case from www.patentdocs.org

By Kevin E. Noonan -- Many of the amicus curiae briefs that have been filed in the en banc rehearing of Therasense, Inc. v. Becton, Dickinson & Co. have mentioned (if not bemoaned) the negative effects the ...

Share via E–mail | Twitter | Facebook

Patent Circle on Facebook and Twitter from patentcircle.blogspot.com

We are extremely happy to be back to blogging after a considerable time gap. Last 10-12 months had been very busy and hectic for us as well as the memorable time of our life as ...

Share via E–mail | Twitter | Facebook

Mylan generic Mirapex violates Boehringer’s patent from patentcircle.blogspot.com

Judge Faith S. Hochberg of the District Court of the District of New Jersey lately ruled in the favor of Boehringer Ingelheim and found Boehringer’s US Patent Number 4,886,812 infringed and violated ...

Share via E–mail | Twitter | Facebook

Followup on Michigan State University plagiarism from ipbiz.blogspot.com

The Grand Rapids Press gave some specifics on what has asserted to have been plagiarized in the report by a Michigan State researcher:

A 13-page portion of Shakrani's report discussing consolidation issues was criticized ...

Share via E–mail | Twitter | Facebook

RIM’s Battle for Information Privacy, Market Share, and its Reputation from www.iposgoode.ca

Robert Dewald is a J.D. Candidate at Osgoode Hall Law School  Canadian telecommunications giant Research in Motion (RIM), which manufacturers the popular BlackBerry, has reportedly offered information and tools to assist India’s government ...

Share via E–mail | Twitter | Facebook

Techdirt praises PatentlyO on patent grant rate data from ipbiz.blogspot.com

from a post at TechDirt:

The numbers don't lie, and the always excellent PatentlyO blog has the numbers and the graphs to show that we haven't just increased the rate of patent approvals ...

Share via E–mail | Twitter | Facebook

Second Circuit Holds That Shipping a Single Counterfeit Item to New York May Support Personal Jurisdiction When Combined with Other Business Activity in New York from www.iplawalert.com

On August 5, 2010, the Second Circuit issued an important decision affecting a brand owner’s ability to establish personal jurisdiction against out-of-state defendants involved in the online sale of counterfeit goods. In Chloe v ...

Share via E–mail | Twitter | Facebook

Patent Attorney Backgrounds from www.patentlyo.com

Professors Ralph Clifford, Tom Field, and Jon Cavicchi have published an interesting study on the technical backgrounds of patent attorneys and agents. After the trio submitted a FOIA request, the PTO handed-over 50,000 pages ...

Share via E–mail | Twitter | Facebook

The changing music business from www.athenaalliance.org

Here is an interesting aside in a recent Wall Street Journal story on the latest problems of the music company EMI:

Sales of recorded music have tumbled over the last decade, as digital downloads opened ...

Share via E–mail | Twitter | Facebook

More on manufacturing from www.athenaalliance.org

FYI -- from Bill Strauss, Economic Advisor and Senior Economist with the Chicago Fed -
Midwest Economy: Is U.S. Manufacturing Disappearing? -- its all about productivity. And manufacturing is doing quite well in that category, thank you ...

Share via E–mail | Twitter | Facebook

Fresenius Medical Sues Amneal Pharmaceuticals for Generic Copy of PhosLo® GelCaps from www.infringementupdates.com

Fresenius Medical Care Holdings, Inc. v. Amneal Pharmaceuticals, LLC was filed on August 19, 2010 in the U.S. District Court for the District of Massachusetts (Civil Action No. 1:10-cv-11429-RGS).

The following is excerpted ...

Share via E–mail | Twitter | Facebook

BioNetwork West 2010: Pharmaceutical-Biotech Partnering Conference from www.patentbaristas.com

BioNetwork West 2010

The 8th Annual Pharmaceutical-Biotech Partnering Conference

There are a lot of pharmaceutical and biotechnology investment conferences and Pharma-Biotech networking events in the market.  BioNetwork is offering a conference that offers you the ...

Share via E–mail | Twitter | Facebook

Aurobindo and Torrent loses Uroxatral patent lawsuit from patentcircle.blogspot.com

Judge Gregory Sleet of the US District Court for the District of Delaware lately decided in favor of Sanofi-Aventis in Uroxatral patent lawsuit and ruled that Sanofi’s US Patent Number 4,661,491 is ...

Share via E–mail | Twitter | Facebook

"Bundle breaker" patent broken from ipbiz.blogspot.com

The patentee lost in Martin v. Alliance, with claims
found obvious:

Following a trial for patent infringement that resulted
in a hung jury, the United States District Court for the
Northern District of California ruled ...

Share via E–mail | Twitter | Facebook

You make the inference from ipbiz.blogspot.com

Part of Bob Park's WN on 20 August 2010 includes the following:

Last week I commented about Conservapedia, which was created to counter the "liberal bias of Wikipedia." As an example, I quoted from ...

Share via E–mail | Twitter | Facebook

USPTO Announces Agenda for Next BCP Customer Partnership Meeting from www.patentdocs.org

The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting to be held on September 8, 2010. The proposed agenda is as follows: Morning ...

Share via E–mail | Twitter | Facebook